Stein_General_0.png

Welcome to ADAA's Professional Community

ADAA is the only multidisciplinary professional organization in mental health that engages the world’s leading experts who focus on anxiety, depression and co-occurring disorders. Engaging a membership of more than 1,800 professionals, ADAA strives to improve patient care by promoting implementation of evidence-based treatments and best practices across disciplines through trainings, continuing education and accelerating dissemination of research into practice.

  ADAA promotes scientific innovation and engages a diverse network of clinicians and basic and clinical anxiety and depression researchers with diverse backgrounds in medicine, psychology, social work, counseling, nursing, neuroscience, genetics, epidemiology, and other disciplines to advance science and new treatments. 

⇒  ADAA member dues help support the free information and resources that are provided to the more than 25 million annual website visitors to www.adaa.org. Membership dues also help fund the research that will one day prevent and cure anxiety, depression and related disorders. 

Member News and Program Updates

Ever wonder why you get “butterflies” in your stomach before doing something stressful? Or why you feel like your stomach is “tied in knots” after an argument? Ever had a meeting with a toilet that went longer than expected and it wasn’t caused by anything you ate?  Stomach problems are one of the most common symptoms of stress and anxiety. ADAA member Ken Goodman, LCSW, authors this blog post on how to calm an anxious stomach.
ADAA member Kirstin Gilbert, PhD shares the connection between excessive self-control and perfectionism and risk for OCD. 
ADAA member Ellen Hendriksen, PhD, talks about the different types of social anxiety in this article. 
"Notwithstanding the proven prevalence of PTSD among various populations, little has been done to spur innovation for new therapies. According to Israel Liberzon, MD (ADAA member), a professor of psychiatry, psychology, and neuroscience at the University of Michigan, SSRIs—specifically sertraline (approved in 1999) and paroxetine (approved in 2001)—are the only medications currently approved by the US Food and Drug Administration for the specific treatment of PTSD."